+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

External radiation therapy of prostatic carcinoma and its relationship to hormonal therapy

External radiation therapy of prostatic carcinoma and its relationship to hormonal therapy

Radiation Medicine 13(6): 297-300

From 1980 to 1990, a total of 54 patients with prostatic carcinoma were treated with external radiation therapy at the Kumamoto National Hospital. Ten patients were classified as Stage B, 22 as Stage C, and another 22 as Stage D according to the American Urological Association Clinical Staging System. The 5-year survival for all 54 patients was 30%. The 5-year disease-specific survival was 67% for Stage B, 47% for Stage C, and 26% for Stage D. The 5-year survival was 43% for patients in whom radiation therapy was initiated immediately after the first diagnosis or with less than one year of hormonal therapy, while it was 0% for patients in whom radiation therapy was initiated after more than one year of hormonal therapy (p = 0.01). The cause of intercurrent death was acute myocardial infarction in four patients and acute cardiac failure in one. Four of these patients received hormonal therapy for more than one year. The incidence of radiation-induced proctitis was not severe. This study suggests that long-term hormonal therapy prior to radiation therapy worsens the prognosis of patients with prostatic carcinoma.

(PDF 0-2 workdays service: $29.90)

Accession: 046057228

Download citation: RISBibTeXText

PMID: 8850371

Related references

A comparison of treatments of squamous cell carcinoma of the base of tongue: surgical resection combined with external radiation therapy, external radiation therapy alone, and external radiation therapy combined with interstitial radiation. BrachyTherapy 3(4): 240-245, 2004

Extended field radiation therapy vs. delayed hormonal therapy in node positive prostatic adeno carcinoma. Journal of Urology 127(5): 935-937, 1982

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology 45(4): 616-623, 1995

Combined hormonal and radiation therapy for prostatic carcinoma. Strahlentherapie und Onkologie 167(9): 523-529, 1991

Prostatic carcinoma. External radiation therapy. Journal of the Kansas Medical Society 83(10): 479-483, 1982

Neoadjuvant combined hormonal therapy and radiotherapy with external beam irradiation in prostatic carcinoma. La Radiologia Medica 93(4): 446-450, 1997

The combined radiation and hormonal therapy of prostatic carcinoma: a conceptual analysis. Strahlentherapie und Onkologie 167(9): 523-529, 1991

Treatment of prostatic carcinoma in clinical stage C. Comparison between radiotherapy plus hormonal therapy after progression and immediate hormonal therapy. Minerva Urologica E Nefrologica 46(2): 123-128, 1994

Radical external radiation therapy of localized prostatic carcinoma. Tenth International Congress of Radiology Book of Abstracts, Montreal, Quebec, Canada No 923(b) p 273, 1962

Reduced incidence of bone metastases in irradiated areas after external radiation therapy of prostatic carcinoma. International Journal of Radiation Oncology, Biology, Physics 20(6): 1297-1304, 1991

Glycoprotein A-80 in the human prostate: Immunolocalization in prostatic intraepithelial neoplasia, carcinoma, radiation failure, and after neoadjuvant hormonal therapy. Urology 61(1): 248-252, January, 2003

Extended field radiation therapy versus delayed hormonal therapy in node positive prostatic adenocarcinoma. Journal of Urology 127(5): 935-937, 1982

Low and intermediate risk prostate cancer-- role of hormonal therapy with external beam radiation therapy. Canadian Journal of Urology 13 Suppl 2: 63-67, 2006

Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy. International Journal Of Radiation Oncology Biology Physics. 29(4): 755-761, 1994